957 related articles for article (PubMed ID: 9649686)
1. Post-kala-azar dermal leishmaniasis.
Baghestani S; Handjani F; Sodeifi M; Kumar PV
Eur J Dermatol; 1998 Jun; 8(4):277-9. PubMed ID: 9649686
[TBL] [Abstract][Full Text] [Related]
2. An unusual presentation of post-kala-azar dermal leishmaniasis.
Ramesh V; Kumar J; Salotra P
Trop Doct; 2007 Jul; 37(3):172-3. PubMed ID: 17716510
[TBL] [Abstract][Full Text] [Related]
3. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
[TBL] [Abstract][Full Text] [Related]
4. Kala-azar in Afghanistan.
Singh M; Arya LS; Aram GN; Fazal MI; Qureshi MA; Goel RG
J Trop Med Hyg; 1982 Oct; 85(5):201-4. PubMed ID: 7176002
[TBL] [Abstract][Full Text] [Related]
5. Oral miltefosine in post-kala-azar dermal leishmaniasis--experience in three cases.
Khandpur S; Chaturvedi P; Kumar U; Khaitan BK; Samantaray JC; Sharma VK
Int J Dermatol; 2010 May; 49(5):565-9. PubMed ID: 20534094
[No Abstract] [Full Text] [Related]
6. Post-kala-azar dermal leishmaniasis (PKDL): the first case report from Nepal.
Karki P; Koirala S; Parija SC; Sethi M; Das ML
Southeast Asian J Trop Med Public Health; 2003 Mar; 34(1):22-3. PubMed ID: 12971510
[TBL] [Abstract][Full Text] [Related]
7. Visceral kala-azar associated with post-kala-azar dermal leishmaniasis.
Singh NK; Agrawal SK; Jha TK
J Assoc Physicians India; 1989 Feb; 37(2):191. PubMed ID: 2808294
[TBL] [Abstract][Full Text] [Related]
8. Cure of antimony-unresponsive Indian post-kala-azar dermal leishmaniasis with oral miltefosine.
Sundar S; Kumar K; Chakravarty J; Agrawal D; Agrawal S; Chhabra A; Singh V
Trans R Soc Trop Med Hyg; 2006 Jul; 100(7):698-700. PubMed ID: 16325873
[TBL] [Abstract][Full Text] [Related]
9. Histopathological characteristics of post kala-azar dermal leishmaniasis: a series of 88 patients.
Singh A; Ramesh V; Ramam M
Indian J Dermatol Venereol Leprol; 2015; 81(1):29-34. PubMed ID: 25566893
[TBL] [Abstract][Full Text] [Related]
10. Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
Das VN; Pandey K; Verma N; Lal CS; Bimal S; Topno RK; Singh D; Siddiqui NA; Verma RB; Das P
Am J Trop Med Hyg; 2009 Mar; 80(3):336-8. PubMed ID: 19270277
[TBL] [Abstract][Full Text] [Related]
11. Diffuse cutaneous leishmaniasis in an HIV-positive patient in western Africa.
Niamba P; Goumbri-Lompo O; Traoré A; Barro-Traoré F; Soudré RT
Australas J Dermatol; 2007 Feb; 48(1):32-4. PubMed ID: 17222299
[TBL] [Abstract][Full Text] [Related]
12. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of post-kala-azar dermal leishmaniasis (PKDL) in a HIV infected patient with multiple relapsing leishmaniasis from Western Europe.
Rihl M; Stoll M; Ulbricht K; Bange FC; Schmidt RE
J Infect; 2006 Jul; 53(1):e25-7. PubMed ID: 16274744
[TBL] [Abstract][Full Text] [Related]
14. Blindness following visceral leishmaniasis: a neglected post-kala-azar complication.
Khalil EA; Musa AM; Younis BM; Elfaki ME; Zijlstra EE; Elhassan AM
Trop Doct; 2011 Jul; 41(3):139-40. PubMed ID: 21676981
[TBL] [Abstract][Full Text] [Related]
15. Post-kala-azar dermal leishmaniasis as an immune reconstitution inflammatory syndrome in a patient with acquired immune deficiency syndrome.
Antinori S; Longhi E; Bestetti G; Piolini R; Acquaviva V; Foschi A; Trovati S; Parravicini C; Corbellino M; Meroni L
Br J Dermatol; 2007 Nov; 157(5):1032-6. PubMed ID: 17854365
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological aspects of kala-azar in Meshkin-Shahr, Iran: human infection.
Soleimanzadeh G; Edrissian GH; Movahhed-Danesh AM; Nadim A
Bull World Health Organ; 1993; 71(6):759-62. PubMed ID: 8313493
[TBL] [Abstract][Full Text] [Related]
17. Visceral childhood leishmaniasis in southern Turkey: experience of twenty years.
Dursun O; Erişir S; Yeşilipek A
Turk J Pediatr; 2009; 51(1):1-5. PubMed ID: 19378883
[TBL] [Abstract][Full Text] [Related]
18. Post kala-azar dermal leishmaniasis (PKDL): a first case report from Nepal.
Karki P; Koirala S; Parija SC; Sethi M; Das ML
Indian J Pathol Microbiol; 2003 Apr; 46(2):214-5. PubMed ID: 15022913
[TBL] [Abstract][Full Text] [Related]
19. Kala azar with disseminated dermal leishmaniasis.
Kumar PV; Sadeghi E; Torabi S
Am J Trop Med Hyg; 1989 Feb; 40(2):150-3. PubMed ID: 2919725
[TBL] [Abstract][Full Text] [Related]
20. Post-kala-azar dermal leishmaniasis simulating leprosy. (A case report).
Lal S; Garg BR
Lepr India; 1976 Jan; 48(1):81-3. PubMed ID: 191696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
